Integrating Genomic and Clinicopathologic Risk Groups May Im

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.

Related Keywords

Michigan , United States , , Veracyte Inc , Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting , Decipher Genomics Resource , Intelligent Discovery ,